Account statements as of June 30, 2020, are available via the Client Access link. We have also prepared the Q2 investor letter from Charles Buck, President and CEO, which includes preliminary performance information for Q2-2020.
We at United Church Funds are deeply concerned about what is happening throughout our nation. UCF is recommitting to using the proven and powerful strategy of responsible investing: investing to make a difference.
Today, 23.9% of voting shareholders of AbbVie, a U.S. pharmaceutical company, supported a United Church Funds-led shareholder resolution to report on the “feasibility of incorporating public concern over high drug price into the senior executive compensation arrangement.”
United Church Funds is proud to have coordinated a shareholder resolution with Gilead Sciences, Inc. that received 43.4% support at Gilead’s annual general meeting on May 6, 2020. The resolution requested the company to separate the position of the Chair of the Board from the CEO position.
United Church Funds talked with Rev. John H. Pomeroy, Co-Pastor at First Congregational Church of Pasadena, to learn about the church’s history, mission, and how they deepen their impact in the community through socially responsible investing.
Matt Wagner, Director, Institutional Relationships, discussed with David Klassen, Chief Investment Strategist, the impact of COVID-19 on the global market, what recovery looks like and the benefits of diversification.
United Church Funds, along with investor members of the Interfaith Center on Corporate Responsibility, sent letters to the CEOs of 14 pharmaceutical companies, calling for a collaborative approach in the development of health technologies, including diagnostics, treatments and a vaccine in the global fight against COVID-19.
Account statements as of March 31, 2020 are available via the Client access link at the top of this page using your login and password. We have provided our investor letter from Charles Buck, President and CEO, and the preliminary performance information for Q1-2020.